RN7SL178P

Across TCGA pan-cancer cohorts, RN7SL178P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL178P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL178P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL178P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

HNSC, ESCA, and THCA are the cancer types where RN7SL178P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.001	0.712	<.001	72	view →
ESCA	DFS	Tertile	All	0.487	0.289	.002	49	view →
THCA	DFS	Tertile	II,III,IV	0.467	0.911	<.001	45	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
LUSC	OS	Tertile	All	0.557	0.782	.002	39	view →
STAD	DFS	Quartile	All	0.463	0.587	.005	19	view →
KIRC	DFS	Tertile	IV	0.410	0.635	.035	18	view →
SARC	OS	Tertile	All	0.108	0.827	<.001	18	view →
THYM	DFS	Tertile	All	0.134	0.871	<.001	9	view →
COAD	OS	Tertile	III,IV	0.239	0.791	.014	9	view →
KIRP	DFS	Tertile	All	0.255	0.618	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL178P–HNSC (OS)

Open the HNSC breakdown →